The FDA approved the Farapulse pulsed field ablation (PFA) system for paroxysmal atrial fibrillation (Afib or AF), Boston Scientific announced on Wednesday. The device won an indication for the ...

A new staged framework for atrial fibrillation (Afib) classification was proposed in updated U.S. guidelines. Afib catheter ablation gained a broader class I recommendation from the American College ...

New Global IDE Study is Evaluating the DiamondTemp™ Ablation System in Persistent Atrial Fibrillation SANTA CLARA, California, Oct. 4, 2018 /PRNewswire/ -- EPIX Therapeutics, Inc., a medical device ...

DEAR DR. ROACH: I am an 88-year-old female in relatively good health. A year and a half ago, I did experience atrial fibrilliation and had two cardioversions. (The first was good for a year; the ...

The complete study cohort includes 1,023 patients from 22 sites in Europe.

Pulmonary-vein isolation is an effective treatment for paroxysmal atrial fibrillation. Pulsed field ablation (PFA) is a nonthermal ablation method with few adverse effects beyond the myocardium. Data ...

Boston Scientific shared the results during a late-breaking presentation at this year’s EHRA congress in Paris, France.

One-year clinical trial data for the next-generation, investigational, Sphere-360™ single-shot PFA catheter show impressive safety, performance, and efficiency results for paroxysmal Afib Dual-energy ...

In the U.S., the incidence of atrial fibrillation, the most common arrhythmia in the world, has more than doubled since 2010, increasing from 5 million to 10.5 million. Each year, 250,000 new cases ...

First-of-its-kind, rotation-free single-shot PFA catheter supported by strong safety and efficacy data adds to the groundbreaking Affera family of technologies in Europe Successful completion of first ...

IRVINE, Calif., Nov. 2, 2023 /PRNewswire/ -- Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i announced new findings from the Q-FFICIENCY ...

GALWAY, Ireland, Jan. 23, 2026 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced two major milestones for the Affera™ Sphere-360™ catheter, a first-of ...